Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
07-2020 | 04-2020 | 01-2020 | 10-2019 | 07-2019 | |
Operating Expenses | 2,436 | 2,670 | 2,630 | 2,129 | 2,184 |
Operating Income | -2,436 | -2,670 | -2,630 | -2,129 | -2,184 |
Other Income | -141 | 12 | 13 | 18 | 18 |
Pre-tax Income | -2,577 | -2,658 | -2,617 | -2,111 | -2,166 |
Net Income Continuous | -2,577 | -2,658 | -2,617 | -2,111 | -2,166 |
Minority Interests | -15 | -18 | -24 | -24 | -26 |
Net Income | $-2,562 | $-2,640 | $-2,593 | $-2,088 | $-2,140 |
EPS Basic Total Ops | -0.11 | -0.12 | -0.13 | -0.10 | -0.11 |
EPS Basic Continuous Ops | -0.11 | -0.13 | -0.13 | -0.10 | -0.11 |
EPS Diluted Total Ops | -0.11 | -0.12 | -0.13 | -0.10 | -0.11 |
EPS Diluted Continuous Ops | -0.11 | -0.13 | -0.13 | -0.10 | -0.11 |
EBITDA(a) | $-2,414 | $-2,643 | $-2,603 | $-2,114 | $-2,128 |